The Alliance for Natural Health has prepared petitions for three vitally
important issues. Please consider signing them.

 

1) Pharmaceutical executives getting high-ranking jobs in the FDA; former
FDA employees going to work for Big Pharma. This revolving door between
regulator and industry is the very definition of the "fox guarding the
henhouse." This cronyism is putting Americans lives at risk and it needs to
stop.  <http://aahf.convio.net/site/Advocacy?pagename=homepage&id=3575>
Action Alert!

2) There is a bill in Congress, the Rural Broadband Acceleration Act, which
would direct the Federal Communications Commission (FCC) to accelerate an
FCC program designed to bring broadband to rural communities and small
businesses. Separately, the FCC passed an order to make it easier for
companies to install 5G in rural communities by streamlining the process to
upgrade existing towers to 5G.
<http://aahf.convio.net/site/Advocacy?pagename=homepage&id=3582> Action
Alert!

 

3) Estriol and other bioidentical hormones have been nominated to the FDA's
Demonstrably Difficult to Compound List; items that appear on the list when
it is final will no longer be able to be made at compounding pharmacies. We
need to let the FDA know that we're watching.
<http://aahf.convio.net/site/Advocacy?pagename=homepage&id=3579> Action
Alert!

    Also, for those who can: On July 1, the National Academy of Sciences,
Engineering, and Medicine (NASEM) is holding a webinar to release their
report on the "clinical utility" of compounded bioidentical hormone
replacement therapy. We expect the FDA will use this report as ammunition to
ban estriol and other bioidentical hormones from pharmacy compounding. It is
critical that consumers
<https://www.eventbrite.com/e/report-release-compounded-bioidentical-hormone
-therapy-tickets-109029542296?utm_source=HMD+Email+List&utm_campaign=6f89917
a02-EMAIL_CAMPAIGN_2020_02_14_04_54_COPY_02&utm_medium=email&utm_term=0_2116
86812e-6f89917a02-180639765&mc_cid=6f89917a02&mc_eid=0ee6da7aba> attend this
webinar to let the FDA know that we're watching them.

 

Thank you.

Nenah Sylver, PhD